KACI CINNAMON-BURTON: Open Payments
NPI 1972917474 · PORT NECHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 41 payments from 11 companies in 2025. Trend: 2023 $306 · 2024 $293 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $171 |
| Novo Nordisk Inc | 9 | $149 |
| Kowa Pharmaceuticals America, Inc. | 5 | $85 |
| Lilly USA, LLC | 5 | $80 |
| PFIZER INC. | 3 | $60 |
| Amgen Inc. | 2 | $43 |
| Antares Pharma, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Wegovy, ZORYVE, QULIPTA, MOUNJARO, UBRELVY, REPATHA, ELIQUIS, VRAYLAR.
Industry payments across TX — which companies pay providers there.
